Neural stem cell transplantation improves spatial learning and memory via neuronal regeneration in amyloid-β precursor protein/presenilin 1/tau triple transgenic mice

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 2, 2014, Pages 142-149

  Chen, Shuang Qing ^a   Cai, Qing ^a   Shen, Yu Ying ^a   Wang, Pei Yun ^b   Li, Ming Hua ^b   Teng, Gao Yun ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Alzheimer's disease; neural stem cells; transplantation; triple transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; NESTIN; PRESENILIN; TAU PROTEIN; MAPT PROTEIN, MOUSE; MONOCLONAL ANTIBODY; PRESENILIN 1; PRESENILIN 1, MOUSE; TAU-1 MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COGNITIVE DEFECT; CONTROLLED STUDY; FETUS; FROZEN SECTION; HIPPOCAMPUS; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL; NERVE REGENERATION; NEURAL STEM CELL TRANSPLANTATION; NISSL STAINING; NONHUMAN; SPATIAL LEARNING; SPATIAL MEMORY; TRANSGENIC MOUSE; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; LEARNING; MALE; METABOLISM; NEURAL STEM CELL; PHYSIOLOGY; REGENERATION; STEM CELL TRANSPLANTATION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; LEARNING; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL STEM CELLS; NEURONS; PRESENILIN-1; REGENERATION; SPATIAL MEMORY; STEM CELL TRANSPLANTATION; TAU PROTEINS;

EID: 84898959114     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513506776     Document Type: Article

References (35)

1. Ohno M. Failures to reconsolidate memory in a mouse model of Alzheimer's disease. Neurobiol Learn Mem. 2009 ; 92 (3). 455-459
2. Hagan JJ, Salamone JD, Simpson J, Iversen SD, Morris RG. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Brain Res. 1988 ; 27 (1). 9-16
3. Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci. 2007 ; 27 (44). 11925-11933
4. Youdim MB, Buccafusco JJ. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol Sci. 2005 ; 26 (1). 27-35
5. Shihabuddin LS, Aubert I. Stem cell transplantation for neurometabolic and neurodegenerative diseases. Neuropharmacology. 2010 ; 58 (6). 845-854
6. Cattaneo E, McKay R. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature. 1990 ; 347 (6295). 762-765
7. Kempermann G, Gage FH. Neurogenesis in the adult hippocampus. Novartis Found Symp. 2000 ; 231: 220-235
8. Xuan AG, Luo M, Ji WD, Long DH. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci Lett. 2009 ; 450 (2). 167-171
9. Xuan AG, Long DH, Gu HG, Yang DD, Hong LP, Leng SL. BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix. Neurosci Lett. 2008 ; 440 (3). 331-335
10. Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003 ; 39 (3). 409-421
11. Braidy N, Muñoz P, Palacios AG. Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm. 2012 ; 119 (2). 173-195
12. Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol. 1991 ; 82 (4). 239-259
13. Cummings J. Alzheimer's disease: from molecular biology to neuropsychiatry. Semin Clin Neuropsychiatry. 2003 ; 8 (1). 31-37
14. Amritraj A. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains. Neurobiol Aging. 2009 ; 30 (1). 54-70
15. Kobayashi DT, Chen KS. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav. 2005 ; 4 (3). 173-196
16. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003 ; 348 (14). 1333-1341
17. Schneider LS, Olin JT. Overview of clinical trials of hydergine in dementia. Arch Neurol. 1994 ; 51 (8). 787-798
18. Hendriksen JV, Nottet HS, Smits HA. Secretases as targets for drug design in Alzheimer's disease. Eur J Clin Invest. 2002 ; 32 (1). 60-66
19. Anderson DJ, Michelsohn A. Role of glucocorticoids in the chromaffin-neuron developmental decision. Int J Dev Neurosci. 1989 ; 7 (5). 475-487
20. Johnasson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J. Identification of a neural stem cell in the adult mammalian central nerve system. Cell. 1999 ; 96 (1). 25-34
21. Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol. 2001 ; 19 (12). 1129-1133
22. Mishina M, Sakimura K. Conditional gene targeting on the pure C57BL/6 genetic background. Neurosci Res. 2007 ; 58 (2). 105-112
23. Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E.. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3×Tg-AD). Behav Brain Res. 2012 ; 234 (2). 334-342
24. Feng ZL, Gao F. Stem cell challenges in the treatment of neurodegenerative disease. CNS Neurosci Ther. 2012 ; 18 (2). 142-148
25. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation and amyloid plaques in transgenic mice. Science. 1996 ; 274 (5284). 99-102
26. Isomae K, Morimoto S, Hasegawa H, Morita K, Kamei J. Effects of T-82, a novel acetylcholinesterase inhibitor, on impaired learning and memory in passive avoidance task in rats. Eur J Pharmacol. 2003 ; 465 (1-2). 97-103
27. Zawanz J. From empiricism to neuroscience in Alzheimer's disease. Rev Neurol. 2004 ; 39 (6). 576-582
28. Geula C, Nagykery N, Nicholas A, Wu CK. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol. 2008 ; 67 (4). 309-318
29. Schwarz SC, Schwarz J. Translation of stem cell therapy for neurological diseases. Transl Res. 2010 ; 156 (3). 155-160
30. Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA. 2009 ; 106 (32). 13594-13599
31. Zhan Y, Ma DH, Zhang Y, Chang M, Hu LS. Protective effects of transplanted neural stem cells on the brain of Alzheimer's disease rats. Neural Regen Res. 2010 ; 5 (11). 825-832
32. Kwak YD, Brannen CL, Qu T, et al. Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev. 2006 ; 15 (3). 1-9
33. Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proc Natl Acad Sci USA. 2007 ; 104 (30). l2506-12511
34. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: A dynamic duo in Age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004 ; 27 (10). 589-594
35. Crigler L, Robey RC, Asawachaicharm A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2006 ; 198 (1). 54-64